Isolated splenic metastasis in a patient with two distinct genitourinary malignancies

Article Type

Changed

Wed, 05/26/2021 - 13:56

Display Headline

Author(s)

Splenic metastasis is rare, occurring in 2.3%- 7.1% of cases, of which 95% are carcinomas.¹ The lung is the most common primary tumor site (21% of cases), followed by the gastrointestinal system, breast, ovaries, and skin. In a retrospective study evaluating the clinical and pathological impact of splenic metastases during a 25-year period in China, it was found that about 5.3% of metastases were isolated splenic metastasis.² Isolated splenic metastasis from kidney cancer is very rare and is often an incidental finding. Here we report a case with isolated splenic metastasis in a patient with both primary renal cell carcinoma and prostate cancer, which turned out to be metastatic renal cell carcinoma in the spleen.

Click on the PDF icon at the top of this introduction to read the full article.

Article PDF

JCSO_june_229_Zhang_Case.pdf

Issue

The Journal of Community and Supportive Oncology - 13(6)

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology

Topics

Genitourinary Cancer

Patient & Survivor Care

Gastroenterology

Gastrointestinal Cancer

Page Number

229-230

Legacy Keywords

splenic metastasis, renal cell carcinoma, prostate cancer, metastatic renal cell carcinoma, spleen

Sections

Case Reports

Author(s)

Lulu Zhang et al

Author(s)

Lulu Zhang et al

Article PDF

JCSO_june_229_Zhang_Case.pdf

Article PDF

JCSO_june_229_Zhang_Case.pdf

Splenic metastasis is rare, occurring in 2.3%- 7.1% of cases, of which 95% are carcinomas.¹ The lung is the most common primary tumor site (21% of cases), followed by the gastrointestinal system, breast, ovaries, and skin. In a retrospective study evaluating the clinical and pathological impact of splenic metastases during a 25-year period in China, it was found that about 5.3% of metastases were isolated splenic metastasis.² Isolated splenic metastasis from kidney cancer is very rare and is often an incidental finding. Here we report a case with isolated splenic metastasis in a patient with both primary renal cell carcinoma and prostate cancer, which turned out to be metastatic renal cell carcinoma in the spleen.

Click on the PDF icon at the top of this introduction to read the full article.

Splenic metastasis is rare, occurring in 2.3%- 7.1% of cases, of which 95% are carcinomas.¹ The lung is the most common primary tumor site (21% of cases), followed by the gastrointestinal system, breast, ovaries, and skin. In a retrospective study evaluating the clinical and pathological impact of splenic metastases during a 25-year period in China, it was found that about 5.3% of metastases were isolated splenic metastasis.² Isolated splenic metastasis from kidney cancer is very rare and is often an incidental finding. Here we report a case with isolated splenic metastasis in a patient with both primary renal cell carcinoma and prostate cancer, which turned out to be metastatic renal cell carcinoma in the spleen.

Click on the PDF icon at the top of this introduction to read the full article.

Issue

The Journal of Community and Supportive Oncology - 13(6)

Issue

The Journal of Community and Supportive Oncology - 13(6)

Page Number

229-230

Page Number

229-230

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology